Actively Recruiting
Multicenter Pheochromocytoma and Paraganglioma Evaluation
Led by Felix Beuschlein · Updated on 2020-07-09
1148
Participants Needed
1
Research Sites
1200 weeks
Total Duration
On this page
Sponsors
F
Felix Beuschlein
Lead Sponsor
T
Technische Universität Dresden
Collaborating Sponsor
AI-Summary
What this Trial Is About
Target population: Patients with (1) newly diagnosed or (2) past history of pheochromocytomas and paragangliomas (PPGL) or (3) carrier of genetic mutations in known PPGL susceptibility genes. International multicenter prospective cohort study with randomized intervention (special care follow-up vs. standard care follow-up). All patients will receive instructions about follow-up at the time point of study inclusion. Patients randomized to the standard care follow-up group will be advised to return annually for follow-up according to current routine practice (without active re-scheduling). In contrast, patients randomized to the special care follow-up group will also be advised to return annually for follow-up but these patients will be actively invited, re-scheduled and reminded by the centers to meet scheduled follow-up appointments.
CONDITIONS
Official Title
Multicenter Pheochromocytoma and Paraganglioma Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female patients aged 5 years or older
- Patients with a newly diagnosed pheochromocytoma or paraganglioma (PPGL)
- Patients with a previous history of PPGLs
- Carriers of genetic mutations known to increase risk for PPGLs
- Ability to read, understand, and sign informed consent (parental consent for children)
You will not qualify if you...
- Patients unable to provide informed consent due to impaired mental capacity
- Pregnant women will not undergo Clonidine testing, PET, MIBG scanning, or contrast CT
- Patients with implantable metal or anxiety that prevents MRI cannot undergo MRI scanning
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Zurich
Zurich, Switzerland, 8091
Actively Recruiting
Research Team
F
Felix Beuschlein, M.D.
CONTACT
M
Martin Reincke, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here